ACD BRAIN Initiative Working Group 2.0 Neuroethics Subgroup

Mission and Charge

The ACD Working Group on BRAIN 2.0 Neuroethics Subgroup was formed to develop a Neuroethics Roadmap for the NIH BRAIN Initiative; review priority areas identified in the BRAIN 2025 (PDF) Strategic Plan, incorporating updates from the broader BRAIN 2.0 Working Group; and characterize the neuroethical implications that may arise as BRAIN Initiative investments produce new tool/neurotechnologies, and/or those tools/neurotechnologies are applied to advancing the goals of the NIH BRAIN Initiative. The Neuroethics Subgroup will provide analysis and findings to the Working Group on BRAIN 2.0 for inclusion in the final report.

Workshop

January 23, 2019
National Institutes of Health, Bethesda

* Document is in the process of being made compliant with Section 508 accessibility requirements.

Neuroethics Roadmap

The BNS has conducted a portfolio review and held a public workshop on neuroethical issues posed by research through the BRAIN Initiative. The BNS would now appreciate comments from the public on draft findings and analysis detailed in a Neuroethics Roadmap. The Neuroethics Subgroup has also provided analysis and findings to the Working Group on BRAIN 2.0 for inclusion in the Working Group's initial thoughts. Please submit comments to [email protected] by May 20, 2019. The findings and analysis from the BNS will be presented to the Advisory Committee to the Director, NIH, for consideration at a public meeting on June 13–14, 2019.

Related Links

Roster

  • Adrienne Fairhall, Ph.D.
    University of Washington
  • Christine Grady, Ph.D., MSN
    National Institutes of Health
  • Elizabeth Hillman, Ph.D.
    Columbia University
  • Insoo Hyun, Ph.D.
    Case Western University
  • Andre Machado, M.D, Ph.D.
    Cleveland Clinic
  • Laura Roberts, M.D.
    Stanford University
  • Karen Rommelfanger, Ph.D.
    Emory University
  • Francis Shen, Ph.D.
    University of Minnesota Law School

CO-CHAIRS

  • James Eberwine, Ph.D.
    University of Pennsylvania
  • Jeffrey Kahn, Ph.D., MPH
    Johns Hopkins University

EXECUTIVE SECRETARY

  • Ellen Gadbois, Ph.D.
    National Institutes of Health
    Office of the Director

This page last reviewed on August 28, 2018